Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
China CDC Weekly|June 8, 2026
Between Achievement and Challenge: Examining China's Tuberculosis Control Pathway and Future Directions from a Global PerspectiveYanqiu Zhang, Dingyong Sun, Linqi Diao
China CDC Weekly|March 16, 2026
Machine Learning Models for Predicting Latent Tuberculosis Infection Risk in Close Contacts of Patients with Pulmonary Tuberculosis - Henan Province, China, 2024Dingyong Sun, Xuan Wu, Yanqiu Zhang, et al.
European Journal of Medical Research|January 25, 2026
Effect of glucagon-like peptide-1 receptor agonists on heart rate in non-diabetic individuals with overweight or obesity: a systematic review and pairwise and network meta-analysis of randomized controlled trialsYiwen Zhang, Chuying Zhang, Xuyang Gong, et al.
BMC Public Health|October 8, 2025
Spatiotemporal epidemiological characteristics of human brucellosis in Henan Province, from 1956 to 2023Zhiguo Liu, Ying Ye, Canjun Zheng, et al.
BMJ Open Respiratory Research|April 5, 2024
Whole-course management of chronic obstructive pulmonary disease in primary healthcare: an internet of things-enabled prospective cohort study in ChinaXingru Zhao, Haonan Kang, Yunxia An, et al.
Frontiers in Public Health|March 26, 2026
Injury incidence, determinants, and associated burden among children aged 0-17 years: a cross-sectional study in Henan Province, Central ChinaBingyuan Wang, Wenjie Yang, Luwei Qin, et al.
Scientific Reports|June 29, 2026
Risk factors for pulmonary tuberculosis recurrence in Henan, China, from 2014 to 2024Yanqiu Zhang, Jianguo Jiang, Jiying Xu, et al.
Frontiers in Public Health|April 27, 2026
Healthy aging among community-dwelling older adults aged ≥60 years in China: results from a 2023 cross-sectional studyHui Li, Li Gao, Yan Gao, et al.
Frontiers in Cellular and Infection Microbiology|January 5, 2026
Effect of PPD inoculation on serum cytokine profiles in latent tuberculosis infection populationsWenjing Chang, Dingyong Sun, Yanqiu Zhang, et al.
Signal Transduction and Targeted Therapy|January 17, 2025
Real-world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort studyHaiyu Wang, Guangying Cui, Ming Cheng, et al.
Pageof 1